Results 61 to 70 of about 71,819 (208)
Pharmacovigilance during mass immunization campaign with MenAfrivac τm in Cameroon [PDF]
, 2015 Background. Immunization is one of the most cost effective public health interventions and is estimated to have greatly reduced diseases, disabilities, deaths, and inequities worldwide.
Ateudjieu, Jerome
core +1 more source
Past and Present Vaccinations in Sweden
Acta Paediatrica, EarlyView.
Sven Arne Silfverdal
wiley +1 more source
Experimental Physiology, Volume 111, Issue 7, Page 3280-3293, 1 July 2026.Abstract Skin‐mounted sensors are thin, flexible and lightweight electronic devices that enable monitoring of multiple physiological parameters. The aim of this study was to provide pilot evidence for possible utilization of a sensorized patch for capturing the bodily response to hypoxia. The subsequent phases of the study comprised a case report and a
Danilo Bondi +5 more
wiley +1 more source
Human Vaccines & Immunotherapeutics, 2019 Introduction: Bacterial meningitis is one of the leading causes of morbidity and mortality among children and adults. Better understanding of the seroepidemiology of meningitis is critical for both the selection and implementation of an effective ...
Meltem Dinleyici +5 more
doaj +1 more source
Shifting From Systemic to Precision‐Targeted Complement Therapies: Opportunities and Hurdles
European Journal of Immunology, Volume 56, Issue 6, June 2026.Complement therapeutics have expanded considerably, but systemic inhibitors remain limited by infection risks, breakthrough events, and loss of physiological functions. Emerging targeted approaches aim for organ‐, tissue‐, or cell‐specific modulation of complement activity, potentially offering greater precision while reducing treatment burden and ...
Marco Mannes +2 more
wiley +1 more source
Brazilian Journal of Infectious DiseasesIntroduction: Meningitis is a communicable infectious disease with a significant disease burden and possible unfavorable outcomes. In this context, the World Health Organization (WHO) and the Pan American Health Organization (PAHO) developed the roadmap “
Nathália Amaro Schmidt +1 more
doaj +1 more source
Meningococcal Vaccines: Current Status and Emerging Strategies
Vaccines, 2018 Neisseria meningitidis causes most cases of bacterial meningitis. Meningococcal meningitis is a public health burden to both developed and developing countries throughout the world.
Pumtiwitt C. McCarthy +2 more
doaj +1 more source
Bacterial meningitis epidemiology and return of Neisseria meningitidis serogroup A cases in Burkina Faso in the five years following MenAfriVac mass vaccination campaign. [PDF]
PLoS ONE, 2017 Historically, Neisseria meningitidis serogroup A (NmA) caused large meningitis epidemics in sub-Saharan Africa. In 2010, Burkina Faso became the first country to implement a national meningococcal serogroup A conjugate vaccine (MACV) campaign.
Alpha Oumar Diallo +14 more
doaj +1 more source
Tuberculous meningitis: new tools and new approaches required [version 1; peer review: not peer reviewed] [PDF]
, 2019 Tuberculous meningitis is the most severe form of tuberculosis and causes widespread mortality and morbidity. Understanding of the epidemiology and pathogenesis is incomplete, and the optimal diagnosis and treatment are poorly defined.
Thwaites, Guy +2 more
core +1 more source
Human Vaccines & ImmunotherapeuticsWide use of the groundbreaking vaccine MenAfriVac® has eliminated serogroup A meningococcal meningitis in the African meningitis belt and paved the way for elimination of all meningococcal disease outbreaks with the development, licensure, and ...
Mark R. Alderson +7 more
doaj +1 more source